常见遗传决定因素对血红蛋白A1c在多种族人群中2型糖尿病风险和诊断的影响:跨种族全基因组荟萃分析
该跨种族全基因组荟萃分析纳入最多159,940名个体,发现60个与HbA1c相关的常见遗传变异,并分为血糖型、红细胞型或未分类。血糖型遗传评分与2型糖尿病风险升高相关(OR=1.05),而红细胞型评分无关联;在非裔美国人中,G6PD G202A变异显著降低HbA1c水平,可能导致约2%的2型糖尿病成人漏诊。作者建议在非洲裔或G6PD缺乏常见人群中筛查G6PD基因型并考虑使用直接血糖测量或遗传信息调整的HbA1c阈值。
要点
- 血糖型遗传评分与2型糖尿病风险升高相关(OR=1.05),红细胞型评分无关联。
- 非裔美国人中G6PD G202A变异与HbA1c绝对降低相关,可能导致约2%的2型糖尿病成人漏诊。
- 建议在非洲裔或G6PD缺乏常见人群中筛查G6PD基因型,并考虑直接血糖测量或遗传信息调整的HbA1c阈值。
核心结论
- 作者建议在非洲裔或G6PD缺乏常见人群中研究筛查G6PD基因型的可能益处,并联合使用HbA1c诊断2型糖尿病。
- 在G6PD缺乏者中,可能需要采用直接血糖测量或遗传信息调整的HbA1c诊断阈值,以避免漏诊或延迟诊断。
研究设计与样本
- 跨种族全基因组关联荟萃分析,纳入来自82个队列的欧洲、非洲、东亚和南亚 ancestry 个体,最多159,940人。
- 在多民族纵向队列(N=33,241)中测试红细胞型或血糖型变异附加遗传评分与2型糖尿病发病风险的关联。
主要发现
- 共识别60个与HbA1c相关的常见遗传变异;19个血糖型和22个红细胞型变异达到全基因组显著性。
- 血糖型遗传评分与2型糖尿病风险升高相关(每增加一个HbA1c升高等位基因的发病OR=1.05,95%CI 1.04-1.06,p=3×10^-29);红细胞型评分无关联(OR=1.00,95%CI 0.99-1.01,p=0.60)。
- 在欧洲人和亚洲人中,红细胞型变异总体对HbA1c诊断准确性仅有 modest 影响。
- 在非裔美国人中,X连锁G6PD G202A变异(T等位基因频率11%)与HbA1c绝对降低相关:半合子男性每等位基因降低0.81%-单位(95%CI 0.66-0.96),纯合子女性降低0.68%-单位(95%CI 0.38-0.97)。
- G6PD变异可能导致约2%(N=0.65百万,95%CI 0.55-0.74)的非裔美国人2型糖尿病成人通过HbA1c筛查时未被诊断。
关键数值与推荐
- 血糖型遗传评分与2型糖尿病风险:OR=1.05(95%CI 1.04-1.06,p=3×10^-29)。
- 红细胞型遗传评分与2型糖尿病风险:OR=1.00(95%CI 0.99-1.01,p=0.60)。
- G6PD G202A变异与HbA1c降低:半合子男性每等位基因-0.81%-单位(95%CI 0.66-0.96),纯合子女性-0.68%-单位(95%CI 0.38-0.97)。
- G6PD变异可能导致约2%(N=0.65百万,95%CI 0.55-0.74)的非裔美国人2型糖尿病成人漏诊。
临床怎么用
- 作者建议研究在非洲裔或G6PD缺乏常见人群中筛查G6PD基因型联合HbA1c诊断2型糖尿病的可能益处。
- 作者提出在G6PD缺乏者中,可能需要采用直接血糖测量或遗传信息调整的HbA1c诊断阈值,以避免漏诊或延迟诊断。
局限性
- 非欧洲 ancestry 的样本量较小。
- 约三分之一的变异无法分类。
- 需要在大规模多民族队列中进一步研究,同时具备HbA1c、血糖和红细胞性状,以更好地确定未分类变异的生物学作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Glycated hemoglobin (HbA1c) is used to diagnose type 2 diabetes (T2D) and assess glycemic control in patients with diabetes. Previous genome-wide association studies (GWAS) have identified 18 HbA1c-associated genetic variants. These variants proved to be classifiable by their likely biological action as erythrocytic (also associated with erythrocyte traits) or glycemic (associated with other glucose-related traits). In this study, we tested the hypotheses that, in a very large scale GWAS, we would identify more genetic variants associated with HbA1c and that HbA1c variants implicated in erythrocytic biology would affect the diagnostic accuracy of HbA1c. We therefore expanded the number of HbA1c-associated loci and tested the effect of genetic risk-scores comprised of erythrocytic or glycemic variants on incident diabetes prediction and on prevalent diabetes screening performance. Throughout this multiancestry study, we kept a focus on interancestry differences in HbA1c genetics performance that might influence race-ancestry differences in health outcomes. METHODS & FINDINGS: Using genome-wide association meta-analyses in up to 159,940 individuals from 82 cohorts of European, African, East Asian, and South Asian ancestry, we identified 60 common genetic variants associated with HbA1c. We classified variants as implicated in glycemic, erythrocytic, or unclassified biology and tested whether additive genetic scores of erythrocytic variants (GS-E) or glycemic variants (GS-G) were associated with higher T2D incidence in multiethnic longitudinal cohorts (N = 33,241). Nineteen glycemic and 22 erythrocytic variants were associated with HbA1c at genome-wide significance. GS-G was associated with higher T2D risk (incidence OR = 1.05, 95% CI 1.04-1.06, per HbA1c-raising allele, p = 3 × 10-29); whereas GS-E was not (OR = 1.00, 95% CI 0.99-1.01, p = 0.60). In Europeans and Asians, erythrocytic variants in aggregate had only modest effects on the diagnostic accuracy of HbA1c. Yet, in African Americans, the X-linked G6PD G202A variant (T-allele frequency 11%) was associated with an absolute decrease in HbA1c of 0.81%-units (95% CI 0.66-0.96) per allele in hemizygous men, and 0.68%-units (95% CI 0.38-0.97) in homozygous women. The G6PD variant may cause approximately 2% (N = 0.65 million, 95% CI 0.55-0.74) of African American adults with T2D to remain undiagnosed when screened with HbA1c. Limitations include the smaller sample sizes for non-European ancestries and the inability to classify approximately one-third of the variants. Further studies in large multiethnic cohorts with HbA1c, glycemic, and erythrocytic traits are required to better determine the biological action of the unclassified variants. CONCLUSIONS: As G6PD deficiency can be clinically silent until illness strikes, we recommend investigation of the possible benefits of screening for the G6PD genotype along with using HbA1c to diagnose T2D in populations of African ancestry or groups where G6PD deficiency is common. Screening with direct glucose measurements, or genetically-informed HbA1c diagnostic thresholds in people with G6PD deficiency, may be required to avoid missed or delayed diagnoses.
引用
- Wheeler E, Leong A, Liu CT, et al. Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis. PLoS Med. 2017. PMID: 28898252. doi:10.1371/journal.pmed.1002383
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。